Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center, also known as Fred Hutchinson Cancer Research Center, is a nonprofit institution dedicated to the study, prevention, and treatment of cancer. Its core activities encompass basic laboratory research, translational science, and clinical investigations aimed at understanding cancer biology and developing new therapies. The organization provides patient care through its affiliation with the Seattle Cancer Care Alliance, delivering treatments such as chemotherapy, radiation therapy, and bone‑marrow transplantation. It serves a broad market that includes local patients in the Pacific Northwest, participants in national clinical trials, and collaborators in international research networks. The center’s work spans multiple cancer types, with particular emphasis on hematologic malignancies, solid tumors, and immunotherapy approaches. By integrating laboratory discoveries with clinical practice, it seeks to improve survival rates and quality of life for individuals affected by cancer.

Located in Seattle, Washington, the center benefits from close ties to the University of Washington and other regional health‑care entities, which facilitates the sharing of expertise and resources. It employs a multidisciplinary workforce of scientists, physicians, and support staff, although specific headcount figures are not provided in the available sources. Distinguishing attributes of the organization include its pioneering role in bone‑marrow transplantation, its contributions to the development of checkpoint‑inhibitor immunotherapy, and its status as a National Cancer Institute‑designated cancer center. These competencies have earned it recognition as a leading cancer research institution both within the United States and globally. Structurally, Fred Hutchinson Cancer Center operates as an independent nonprofit entity, without a publicly traded parent company or subsidiary relationships disclosed in the material provided. The center’s ongoing commitment to research and clinical care continues to shape advancements in oncology and informs public‑health strategies for cancer prevention and control.